Home > Insider Trading > Filing (0000950170-24-047686)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1703647	Korro Bio Inc.	KRRO	Pharmaceutical Preparations (2834)	472324450

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1768564	New Enterprise Associates 17, L.p.	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	No	No
1796820	Nea Partners 17, L.p.	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	No	No
1796821	Nea 17 Gp, Llc	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-04-22	17,857	$56.00	1,090,793	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Acquired from the Issuer on April 22, 2024 pursuant to a Subscription Agreement dated April 17, 2024.
The securities are directly held by New Enterprise Associates 17, L.P. ("NEA 17") and are indirectly held by NEA Partners 17, L.P. ("NEA Partners 17"), the sole general partner of NEA 17, NEA 17 GP, LLC ("NEA 17 GP"), the sole general partner of NEA Partners 17, and the individual managers of NEA 17 GP (NEA Partners 17, NEA 17 GP and the individual managers of NEA 17 GP (collectively, the "Managers") together, the "Indirect Reporting Persons"). The Mangers are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott Sandell, Paul Walker and Rick Yang. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Indirect Reporting Persons have no pecuniary interest.